Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · May 19, 2024

Tranexamic Acid vs Placebo in Individuals With Intracerebral Haemorrhage Treated Within 2 Hours of Symptom Onset

The Lancet Neurology


Additional Info

The Lancet Neurology
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial
Lancet Neurol 2024 Apr 19;[EPub Ahead of Print], N Yassi, H Zhao, L Churilov, TY Wu, H Ma, HT Nguyen, A Cheung, A Meretoja, DT Mai, T Kleinig, JS Jeng, PMC Choi, PD Duc, H Brown, A Ranta, N Spratt, GC Cloud, HK Wang, R Grimley, K Mahawish, DY Cho, D Shah, TMP Nguyen, G Sharma, V Yogendrakumar, B Yan, EL Harrison, M Devlin, D Cordato, N Martinez-Majander, D Strbian, V Thijs, LM Sanders, D Anderson, MW Parsons, BCV Campbell, GA Donnan, SM Davis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading